Bicheng Ye

Yangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy.

Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy.

Journal: BioFactors (Oxford, England)

Published: August 16, 2024

Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response.

Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response.

Journal: Clinical and experimental medicine

Published: May 10, 2024

A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features.

A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features.

Journal: Frontiers in immunology

Published: May 06, 2024

MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.

MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.

Journal: Cancer biology & therapy

Published: April 25, 2024

Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature.

Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature.

Journal: Journal of cellular and molecular medicine

Published: April 08, 2024

Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma.

Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma.

Journal: Translational oncology

Published: December 04, 2023

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

Journal: Journal of the National Cancer Center

Published: September 05, 2023

Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma.

Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma.

Journal: Frontiers in oncology

Published: June 07, 2023

A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients.

A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients.

Journal: Frontiers in pharmacology

Published: March 23, 2023

Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.

Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.

Journal: Frontiers in endocrinology

Published: March 06, 2023

Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing.

Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing.

Journal: Heliyon

Published: February 27, 2023

Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.

Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: February 12, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026